FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970021175> ?p ?o ?g. }

• W2970021175 abstract "We evaluated the effect of combined use of oral oestrogen (E2) and vaginal progesterone (P) to support luteal phase in antagonist intracytoplasmic sperm injection (ICSI) cycles. We analysed data from 176 patients who underwent ICSI cycles with antagonist protocol. P 90 mg vaginal gel once a day and micronised E2 of 4 mg/day, were started from the day of oocyte pick up and continued to the 12th day of embryo transfer. Group 1 (n = 79) patients received E2 + P for luteal phase support. In group 2 (n = 97) patients, only P 90 mg vaginal gel was used for luteal phase support. There were no significant differences between group 1 and group 2 patients in terms of clinical pregnancy rates (PRs) (26.58% vs. 20.62%, p = .352), early pregnancy loss rates (6.33% vs. 6.19%, p = .969), incidence of luteal vaginal bleeding (8.86% vs. 8.25%, p = .885) and implantation rates (22.8% vs. 16.9%, p = .298). In conclusion, our study showed no beneficial effect of addition of E2 to luteal phase support on clinical PR in antagonist IVF cycles.Impact statementWhat is already known on this subject? Luteal phase deficiency is defined as a disruption in progesterone and oestrogen production after ovulation. It is clear that, luteal phase supplementation to improve the outcomes in invitro fertilisation (IVF) cycles is mandatory. As an iatrogenic complication of assisted reproductive technique, decreased luteal oestrogen and progesterone levels lead to decreased pregnancy rates (PRs) and implantation rates.What the results of this study add? In this study, we aimed to present the role of luteal phase oestrogen administration in GnRH antagonist cycles. A total of 176 cases received progesterone vaginal gel form for luteal phase support. Study group received 4 mg oral oestradiol hemihydrate in addition to progesterone. Compared to previous studies, our study consisted of larger number of patients and we used oestradiol through oral route. We found out that luteal oestradiol support did not improve the clinical PR.What the implications are of these findings for clinical practice and/or further research? Our study showed no beneficial effect of addition of oestradiol to luteal phase support on clinical PR in antagonist IVF cycles." @default.
• W2970021175 created "2019-09-05" @default.
• W2970021175 creator A5008424030 @default.
• W2970021175 creator A5009046363 @default.
• W2970021175 creator A5014887851 @default.
• W2970021175 creator A5041732908 @default.
• W2970021175 creator A5046787902 @default.
• W2970021175 creator A5077970080 @default.
• W2970021175 creator A5088084199 @default.
• W2970021175 creator A5091204232 @default.
• W2970021175 date "2019-08-28" @default.
• W2970021175 modified "2023-09-27" @default.
• W2970021175 title "Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study" @default.
• W2970021175 cites W1966648736 @default.
• W2970021175 cites W1968731596 @default.
• W2970021175 cites W1976673736 @default.
• W2970021175 cites W2020600831 @default.
• W2970021175 cites W2023425530 @default.
• W2970021175 cites W2029937507 @default.
• W2970021175 cites W2034799829 @default.
• W2970021175 cites W2035670423 @default.
• W2970021175 cites W2036149881 @default.
• W2970021175 cites W2038006462 @default.
• W2970021175 cites W2050188832 @default.
• W2970021175 cites W2052024970 @default.
• W2970021175 cites W2059745665 @default.
• W2970021175 cites W2073919540 @default.
• W2970021175 cites W2082161938 @default.
• W2970021175 cites W2085973190 @default.
• W2970021175 cites W2276704693 @default.
• W2970021175 cites W2477008945 @default.
• W2970021175 cites W2488543248 @default.
• W2970021175 cites W2503170604 @default.
• W2970021175 cites W2766871517 @default.
• W2970021175 cites W4239080680 @default.
• W2970021175 doi "https://doi.org/10.1080/01443615.2019.1631765" @default.
• W2970021175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31455122" @default.
• W2970021175 hasPublicationYear "2019" @default.
• W2970021175 type Work @default.
• W2970021175 sameAs 2970021175 @default.
• W2970021175 citedByCount "2" @default.
• W2970021175 countsByYear W29700211752020 @default.
• W2970021175 countsByYear W29700211752021 @default.
• W2970021175 crossrefType "journal-article" @default.
• W2970021175 hasAuthorship W2970021175A5008424030 @default.
• W2970021175 hasAuthorship W2970021175A5009046363 @default.
• W2970021175 hasAuthorship W2970021175A5014887851 @default.
• W2970021175 hasAuthorship W2970021175A5041732908 @default.
• W2970021175 hasAuthorship W2970021175A5046787902 @default.
• W2970021175 hasAuthorship W2970021175A5077970080 @default.
• W2970021175 hasAuthorship W2970021175A5088084199 @default.
• W2970021175 hasAuthorship W2970021175A5091204232 @default.
• W2970021175 hasConcept C126322002 @default.
• W2970021175 hasConcept C134018914 @default.
• W2970021175 hasConcept C143228043 @default.
• W2970021175 hasConcept C160099875 @default.
• W2970021175 hasConcept C16685009 @default.
• W2970021175 hasConcept C170493617 @default.
• W2970021175 hasConcept C187785154 @default.
• W2970021175 hasConcept C2776537878 @default.
• W2970021175 hasConcept C2776885963 @default.
• W2970021175 hasConcept C2777702977 @default.
• W2970021175 hasConcept C2777886879 @default.
• W2970021175 hasConcept C2778278907 @default.
• W2970021175 hasConcept C2779234561 @default.
• W2970021175 hasConcept C29456083 @default.
• W2970021175 hasConcept C512716672 @default.
• W2970021175 hasConcept C54355233 @default.
• W2970021175 hasConcept C71315377 @default.
• W2970021175 hasConcept C71924100 @default.
• W2970021175 hasConcept C86803240 @default.
• W2970021175 hasConceptScore W2970021175C126322002 @default.
• W2970021175 hasConceptScore W2970021175C134018914 @default.
• W2970021175 hasConceptScore W2970021175C143228043 @default.
• W2970021175 hasConceptScore W2970021175C160099875 @default.
• W2970021175 hasConceptScore W2970021175C16685009 @default.
• W2970021175 hasConceptScore W2970021175C170493617 @default.
• W2970021175 hasConceptScore W2970021175C187785154 @default.
• W2970021175 hasConceptScore W2970021175C2776537878 @default.
• W2970021175 hasConceptScore W2970021175C2776885963 @default.
• W2970021175 hasConceptScore W2970021175C2777702977 @default.
• W2970021175 hasConceptScore W2970021175C2777886879 @default.
• W2970021175 hasConceptScore W2970021175C2778278907 @default.
• W2970021175 hasConceptScore W2970021175C2779234561 @default.
• W2970021175 hasConceptScore W2970021175C29456083 @default.
• W2970021175 hasConceptScore W2970021175C512716672 @default.
• W2970021175 hasConceptScore W2970021175C54355233 @default.
• W2970021175 hasConceptScore W2970021175C71315377 @default.
• W2970021175 hasConceptScore W2970021175C71924100 @default.
• W2970021175 hasConceptScore W2970021175C86803240 @default.
• W2970021175 hasLocation W29700211751 @default.
• W2970021175 hasLocation W29700211752 @default.
• W2970021175 hasOpenAccess W2970021175 @default.
• W2970021175 hasPrimaryLocation W29700211751 @default.
• W2970021175 hasRelatedWork W1968731596 @default.
• W2970021175 hasRelatedWork W2034799829 @default.
• W2970021175 hasRelatedWork W2062556473 @default.
• W2970021175 hasRelatedWork W2090981890 @default.
• W2970021175 hasRelatedWork W2338935278 @default.
• W2970021175 hasRelatedWork W2503170604 @default.

• next